Department of Community Dentistry and Behavioral Science, College of Dentistry, University of Florida, Gainesville, FL 32610-3628, USA.
Oral Dis. 2011 Nov;17(8):755-70. doi: 10.1111/j.1601-0825.2011.01840.x. Epub 2011 Aug 4.
Recurrent aphthous stomatitis (RAS) is the most common idiopathic intraoral ulcerative disease in the USA. Aphthae typically occur in apparently healthy individuals, although an association with certain systemic diseases has been reported. Despite the unclear etiopathogenesis, new drug trials are continuously conducted in an attempt to reduce pain and dysfunction. We investigated four controversial topics: (1) Is complex aphthosis a mild form of Behçet's disease (BD)? (2) Is periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome a distinct medical entity? (3) Is RAS associated with other systemic diseases [e.g., celiac disease (CD) and B12 deficiency]? (4) Are there any new RAS treatments? Results from extensive literature searches, including a systematic review of RAS trials, suggested the following: (1) Complex aphthosis is not a mild form of BD in North America or Western Europe; (2) Diagnostic criteria for PFAPA have low specificity and the characteristics of the oral ulcers warrant further studies; (3) Oral ulcers may be associated with CD; however, these ulcers may not be RAS; RAS is rarely associated with B12 deficiency; nevertheless, B12 treatment may be beneficial, via mechanisms that warrant further study; (4) Thirty-three controlled trials published in the past 6 years reported some effectiveness, although potential for bias was high.
复发性阿弗他口炎(RAS)是美国最常见的特发性口腔溃疡性疾病。口疮通常发生在看似健康的个体中,尽管有报道称其与某些系统性疾病有关。尽管病因不明,但仍不断进行新的药物试验,试图减轻疼痛和功能障碍。我们研究了四个有争议的话题:(1)复杂性阿弗他口炎是否是贝切特病(BD)的轻度形式?(2)周期性发热、口疮性口炎、咽炎和腺炎(PFAPA)综合征是否是一种独特的医学实体?(3)RAS 是否与其他系统性疾病(例如乳糜泻(CD)和 B12 缺乏症)有关?(4)是否有新的 RAS 治疗方法?通过广泛的文献检索,包括对 RAS 试验的系统评价,结果表明:(1)在北美和西欧,复杂性阿弗他口炎不是 BD 的轻度形式;(2)PFAPA 的诊断标准特异性低,口腔溃疡的特征需要进一步研究;(3)口腔溃疡可能与 CD 有关;然而,这些溃疡可能不是 RAS;RAS 很少与 B12 缺乏症有关;然而,B12 治疗可能是有益的,其机制值得进一步研究;(4)过去 6 年发表的 33 项对照试验报告了一些疗效,尽管存在高度偏倚的可能性。